Document is current
Any future updates will be listed below
-
Authors
Jakubechova, Jana https://orcid.org/0009-0007-6326-5929
Altanerova, Ursula https://orcid.org/0009-0005-9663-0772
Andrezal, Michal https://orcid.org/0009-0005-5056-1556
Vanova, Dajana https://orcid.org/0009-0002-1237-3536
Zeleznikova, Tatiana
Bartek, Peter
Cihova, Marina
Smolkova, Bozena https://orcid.org/0000-0002-4906-5652
Buocikova, Verona https://orcid.org/0000-0002-2466-9126
Makovicky, Peter
Jakic, Kristina https://orcid.org/0000-0002-8251-5328
Burikova, Monika
Urbanova, Maria
Repaska, Veronika
Spanik, Benjamin
Tomas, Miroslav
Dubovan, Peter
Kolnikova, Georgina
Zdrahal, Zbynek https://orcid.org/0000-0003-3044-5548
Pustka, Vaclav https://orcid.org/0009-0005-9857-3601
Potesil, David https://orcid.org/0000-0003-0390-0904
Altaner, Cestmir https://orcid.org/0000-0001-6998-0885
-
Funding
Funding for this research was provided by:
Agentúra na Podporu Výskumu a Vývoja (APVV-20-0143)
Agentúra na Podporu Výskumu a Vývoja (APVV-20-0143)
Agentúra na Podporu Výskumu a Vývoja (APVV-20-0143)
Agentúra na Podporu Výskumu a Vývoja (APVV-20-0143)
Agentúra na Podporu Výskumu a Vývoja (APVV-20-0143)
Agentúra na Podporu Výskumu a Vývoja (APVV-20-0143)
Agentúra na Podporu Výskumu a Vývoja (APVV-20-0143)
Agentúra na Podporu Výskumu a Vývoja (APVV-20-0143)
Agentúra na Podporu Výskumu a Vývoja (APVV-20-0143)
Central European Institute of Technology (LM2023042)
Central European Institute of Technology (LM2023042)
Central European Institute of Technology (LM2023042)
Vedecká Grantová Agentúra MŠVVaŠ SR a SAV (1/0483/23)
SPP Foundation (No.43092023)
- License Information
-
More Information
Article History
Received: 30 January 2025
Accepted: 13 December 2025
First Online: 20 December 2025
Declarations
:
: All experimental protocols involving cells of human subjects were approved by the Ethical Committee of the National Oncological Institute (Protocol TRU-SK-06) titled Identification of biomarkers for pancreatic cancer, approved 1 st December 2017 and by the Ethics Committee of the St. Elisabeth Cancer Institute (No. 4-2019/EK OUSA) titled Etická komisia No. 4-2019/EK OUSA/from 22.5.2019. All donors of specimens used for pCAFs isolation and propagation were informed about the nature of the study and provided their written informed consent. Similarly, all tissue donors for MSCs isolation agreed with their donation by written informed consent. The human pancreatic cancer cell lines BxPC-3 (ATCC® CRL-1687™), MIA PaCa-2 (ATCC® CRL-1420™), and Su.86.86 (ATCC® CRL-1837™) were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). According to ATCC policies, all human-derived cell lines in their repository are collected and distributed in compliance with applicable regulations and ethical standards. The derivation of these cell lines is described in the original publications: Yunis AA et al., Int J Cancer 1977; Tan MH et al., Cancer Invest 1986; Drucker BT et al., In Vitro Cell Dev. 1988.
: Not applicable.
: The authors declare no competing interests.
